系统性市场与组织变革：对药品与治疗学委员会的影响
Systemic Market and Organizational Changes: Impact on P&T Committees.
作者信息
Vogenberg F Randy, Marcoux Rita, Rumore Martha M
出版信息
P T. 2017 Jan;42(1):28-32.
Abstract
The authors consider market stakeholder consolidation, market-driven efficiency demands, consumerism, and legal enforcement of patient rights related to access to appropriate drugs and posit how future P&T committees may approach these issues.
摘要
作者们考虑了市场利益相关者的整合、市场驱动的效率需求、消费主义以及与获取适当药物相关的患者权利的法律执行情况，并设想了未来的药品与治疗委员会可能如何处理这些问题。
相似文献
1
Systemic Market and Organizational Changes: Impact on P&T Committees.系统性市场与组织变革：对药品与治疗学委员会的影响
P T. 2017 Jan;42(1):28-32.
2
The Children's Health Insurance Program Reauthorization Act Evaluation Findings on Children's Health Insurance Coverage in an Evolving Health Care Landscape.《儿童健康保险计划再授权法案》对不断变化的医疗保健格局下儿童健康保险覆盖情况的评估结果。
Acad Pediatr. 2015 May-Jun;15(3 Suppl):S1-6. doi: 10.1016/j.acap.2015.03.007.
3
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology.21 世纪美国政策改革背景下临床皮肤科的未来思考：《平价医疗法案》和《儿童健康保险计划再授权法案》与皮肤科的替代支付模式。
J Am Acad Dermatol. 2017 Jun;76(6):1213-1217. doi: 10.1016/j.jaad.2017.01.031. Epub 2017 Mar 30.
4
What's at Stake in U.S. Health Reform: A Guide to the Affordable Care Act and Value-Based Care.美国医疗改革的利害关系：《平价医疗法案》与价值医疗指南
Policy Polit Nurs Pract. 2017 May;18(2):61-71. doi: 10.1177/1527154417720935. Epub 2017 Jul 20.
5
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System.21 世纪美国政策改革背景下临床皮肤科的未来思考：《平价医疗法案》和《儿童健康保险计划再授权法案》以及基于绩效的激励支付制度。
J Am Acad Dermatol. 2017 Jun;76(6):1206-1212. doi: 10.1016/j.jaad.2017.01.032. Epub 2017 Mar 30.
6
7
Understanding Value-based Reimbursement Models and Trends in Orthopaedic Health Policy: An Introduction to the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.理解基于价值的报销模式及骨科卫生政策趋势：2015年医疗保险准入与儿童健康保险计划再授权法案（MACRA）简介
J Am Acad Orthop Surg. 2016 Nov;24(11):e136-e147. doi: 10.5435/JAAOS-D-16-00283.
8
9
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) Made Simple for Medical and Radiation Oncologists: A Narrative Review.2015 年《平价医疗法案和儿童健康保险计划再授权法案》（MACRA）对医疗和放射肿瘤学家的简化：叙事性回顾。
JAMA Oncol. 2019 May 1;5(5):723-727. doi: 10.1001/jamaoncol.2018.5631.
10
The Role of Government in Physician Reimbursement.政府在医生报销方面的作用。
Am J Med Sci. 2016 Jan;351(1):52-8. doi: 10.1016/j.amjms.2015.10.014.
引用本文的文献
1
Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.医疗保险处方药计划处方限制在市场后 FDA 黑框警告之后。
J Manag Care Spec Pharm. 2019 Nov;25(11):1201-1217. doi: 10.18553/jmcp.2019.25.11.1201.
2
Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System.高成本药物使用的标准化审查与批准流程在大型学术医疗系统中促进基于价值的医疗服务。
Am Health Drug Benefits. 2018 Apr;11(2):65-73.
3
4
Regulatory Change Versus Legislation Impacting Health Care Decisions and Delivery.影响医疗保健决策与服务的监管变革与立法
P T. 2018 Jan;43(1):34-38.
本文引用的文献
1
Using drugs to discriminate--adverse selection in the insurance marketplace.利用药物进行甄别——保险市场中的逆向选择
N Engl J Med. 2015 Jan 29;372(5):399-402. doi: 10.1056/NEJMp1411376.
Zotero 插件